Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow HUM
Humana Inc. (HUM) P/S ratio
As of 16 October 2026, Humana Inc. (HUM) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.2× (March 2026) to 0.9× (November 2018); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.2× | (8.43%) |
| FY2024 | 0.3× | (52.54%) |
| FY2023 | 0.5× | (19.65%) |
| FY2022 | 0.7× | (5.19%) |
| FY2021 | 0.7× | 2.22% |
| FY2020 | 0.7× | (7.16%) |
| FY2019 | 0.8× | 9.41% |
| FY2018 | 0.7× | 2.34% |
| FY2017 | 0.7× | 24.59% |
| FY2016 | 0.5× | 10.46% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.3× | 115.25% |
| Mar 2026 | 0.2× | (36.07%) |
| Dec 2025 | 0.2× | (3.92%) |
| Sep 2025 | 0.2× | 3.43% |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| CNC Centene Corporation compare | 0.2× |
| MOH Molina Healthcare, Inc compare | 0.2× |
| CI Cigna Group compare | 0.3× |
| CVS CVS Health Corporation compare | 0.3× |
| HUM Humana Inc. | 0.3× |
| ELV Elevance Health, Inc. compare | 0.5× |
| OSCR Oscar Health, Inc. compare | 0.6× |
| UNH UnitedHealth Group Incorporated compare | 0.8× |
| CLOV Clover Health Investments, Corp. compare | 0.9× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement